Apimeds names Eric Sherb CFO effective Oct 1; Interim CFO Erick Frim resigned Sept 29

Apimeds Pharmaceuticals US, Inc.

Erick Frim resigned as Interim CFO effective September 29, 2026; the company said the resignation was not due to any disagreement on operations, policies or practices.
The Board appointed Eric Sherb, age 40, as CFO effective October 1, 2026, serving as principal financial officer and principal accounting officer.
Sherb is a CPA with over 18 years of capital markets experience and founded EMS Consulting Services, LLC in January 2019, where he remains Principal.
Employment Agreement provides a base salary of $60,000 per year; no equity awards granted at signing, and no Item 404(a) transactions or family ties to the Board or executives.
Sherb has been fractional CFO of MindWave Innovations Inc., a wholly owned subsidiary, since February 2026; that engagement terminates with his appointment.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.